2021
DOI: 10.3390/antiox10030485
|View full text |Cite
|
Sign up to set email alerts
|

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future

Abstract: Hydrogen sulfide (H2S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H2S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H2S modulates various components of metabolic syndrome, including obesity and glucose metabolism. This review will discuss studies exhibiting H2S -derived cardioprotective signaling in heart failure with reduced ejection fraction (HFrEF). We wil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 76 publications
(97 reference statements)
0
16
0
Order By: Relevance
“…The current literature clearly demonstrates that H 2 S is an important independent effector 8 11 , as well as an enhancer of NO-mediated signalling events affecting the cardiovascular system 12 14 . A cardioprotective role for H 2 S has been suggested in cardiac arrhythmias, cardiac fibrosis, heart failure, cardiac hypertrophy, ischaemia–reperfusion injury (IRI) and myocardial infarction (MI) 10 . Although the role of H 2 S and its metabolites as biomarkers of human cardiovascular disease (CVD) is not yet well established 15 , improved detection techniques have identified novel sulfide metabolites, including hydropersulfides and polysulfides, and have begun to reveal previously unknown molecular mechanisms and their biological relevance in cardiovascular pathology.…”
Section: Introductionmentioning
confidence: 99%
“…The current literature clearly demonstrates that H 2 S is an important independent effector 8 11 , as well as an enhancer of NO-mediated signalling events affecting the cardiovascular system 12 14 . A cardioprotective role for H 2 S has been suggested in cardiac arrhythmias, cardiac fibrosis, heart failure, cardiac hypertrophy, ischaemia–reperfusion injury (IRI) and myocardial infarction (MI) 10 . Although the role of H 2 S and its metabolites as biomarkers of human cardiovascular disease (CVD) is not yet well established 15 , improved detection techniques have identified novel sulfide metabolites, including hydropersulfides and polysulfides, and have begun to reveal previously unknown molecular mechanisms and their biological relevance in cardiovascular pathology.…”
Section: Introductionmentioning
confidence: 99%
“…There are many pharmacological avenues to achieve this latter goal; H 2 S donors with various release rates have been designed and tested, some of them organelle-targeted, some redox-triggered. These molecules are subject to focused review articles [ 5 , 58 64 ]. Unfortunately, these approaches are currently only in the preclinical stage, with the notable exception of SG-1002, which is a clinical-stage molecule, and which exhibits protective effects in various preclinical models of aging-associated diseases including atherosclerosis, chronic heart failure, and diet-induced obesity [ 61 , 65 68 ].…”
Section: Perspectivesmentioning
confidence: 99%
“…3-MST is more abundant in cardiomyocytes and smooth muscle than CSE and, curiously, deletion of 3-MST protects young mice from reperfusion injury but exacerbates in in older 3-MST -/- mice and predisposes them to hypertension and cardiac hypertrophy [ 155 ]. Additional information can be found in recent reviews [ 156 , 157 , 158 ].…”
Section: Evidence For H 2 S Mediated O 2 Sensing In Various Organ Systems and Tissuesmentioning
confidence: 99%